Translational prospects for human induced pluripotent stem cells

Regenerative Medicine
Marie Csete

Abstract

The pace of research on human induced pluripotent stem (iPS) cells is frantic worldwide, based on the enormous therapeutic potential of patient-specific pluripotent cells free of the ethical and political issues that plagued human embryonic stem cell research. iPS cells are now relatively easy to isolate from somatic cells and reprogramming can be accomplished using nonmutagenic technologies. Access to iPS cells is already paying dividends in the form of new disease-in-a-dish models for drug discovery and as scalable sources of cells for toxicology. For translation of cell therapies, the major advantage of iPS cells is that they are autologous, but for many reasons, perfect immunologic tolerance of iPS-based grafts should not be assumed. This article focuses on the functional identity of iPS cells, anticipated safety and technical issues in their application, as well as a survey of the progress likely to be realized in clinical applications in the next decade.

References

May 15, 1996·Annals of Internal Medicine·V BaussaudC Fourcade
Nov 6, 1998·Science·J A ThomsonJ M Jones
Oct 20, 2006·The New England Journal of Medicine·Dina Gould Halme, David A Kessler
Jan 9, 2007·Toxicology·Y R AhujaK Polasa
Feb 17, 2007·American Journal of Ophthalmology·Tongalp H TezelHenry J Kaplan
Jun 8, 2007·Nature·Keisuke OkitaShinya Yamanaka
Jul 20, 2007·Nature·Janet Rossant
Nov 22, 2007·Science·Junying YuJames A Thomson
Jan 19, 2008·Clinical Pharmacology and Therapeutics·K I Kaitin
Feb 19, 2008·Nature Biotechnology·Kenji OsafuneDouglas A Melton
Mar 25, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ulrich MatznerVolkmar Gieselmann
Apr 9, 2008·Nature Biotechnology·Katja Triller Vrtovec, Christopher Thomas Scott
Jun 25, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·J AstermarkM T Reding
Jul 16, 2008·Advances in Cancer Research·Barak Blum, Nissim Benvenisty
Jul 22, 2008·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Xiaodong ZhaoChia-Lin Wei
Aug 2, 2008·Stem Cells·Maureen L Condic, Mahendra Rao
Aug 12, 2008·Cell·In-Hyun ParkGeorge Q Daley
Aug 30, 2008·Nature·Franz-Josef MüllerJeanne F Loring
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Jan 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dan XuYupo Ma
Feb 5, 2009·Annals of Neurology·Jeffrey D Rothstein
Mar 31, 2009·Nature Biotechnology·Madeleine P BallGeorge M Church
Apr 7, 2009·Cell·Shinya Yamanaka
Apr 22, 2009·Neuroscience Letters·Yasuhiko HiramiMasayo Takahashi
Apr 29, 2009·Cell Stem Cell·Hongyan ZhouSheng Ding
May 22, 2009·Journal of Neural Engineering·Hossein AmeriJames D Weiland
May 26, 2009·Biochemical and Biophysical Research Communications·Tomofumi TanakaKeiichi Fukuda
Jul 1, 2009·Cell·Ryan Conder, Juergen A Knoblich
Jul 11, 2009·Nature Biotechnology·Kyoko MiuraShinya Yamanaka
Jul 21, 2009·Biochemical and Biophysical Research Communications·Noritaka YokooToshio Heike
Jul 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mathew Blurton-JonesFrank M LaFerla

❮ Previous
Next ❯

Citations

Mar 6, 2012·Cellular and Molecular Life Sciences : CMLS·Andre AlconYibing Qyang
Jun 23, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Liang GuoKyle L Kolaja
Jul 17, 2010·Regenerative Medicine·M William Lensch, Mahendra Rao
Mar 13, 2013·Nanomedicine·Eriberto BressanBarbara Zavan
Aug 9, 2011·Annual Review of Pharmacology and Toxicology·Feng CongShih-Min A Huang
Jul 3, 2013·Pharmacological Reviews·George J ChristKarl-Erik Andersson
Jun 15, 2012·Biomaterials·Fa-Ming ChenQing Yu
Dec 6, 2011·Biotechnology Advances·Fa-Ming ChenSongtao Shi
Mar 17, 2011·The Journal of Investigative Dermatology·Jouni Uitto
Jul 31, 2013·Journal of Neuroscience Research·Alexander E StoverPhilip H Schwartz
Mar 29, 2014·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Sara E Patterson, Caroline N Dealy
Sep 10, 2011·Stem Cells International·Rosario Isasi, Bartha M Knoppers
Nov 28, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Saami KhalifianGerald Brandacher
Nov 30, 2013·The British Journal of Ophthalmology·Carl SchubertLarry A Donoso
Apr 26, 2019·Stem Cells and Development·Ana-Maria SeciuOtilia Zarnescu
Nov 15, 2019·Muscle & Nerve·Carrie A KubiakStephen W P Kemp
Jan 5, 2012·Materials·Matthew TreseMichael J Young
Mar 16, 2011·The Medical Journal of Australia·Ian H Kerridge, Aric Bendorf

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Tissue Engineering and Regenerative Medicine
Stefan BajadaNureddin Ashammakhi
Journal of Tissue Engineering and Regenerative Medicine
Hai-Hua SunFa-Ming Chen
© 2021 Meta ULC. All rights reserved